The mission of Leaps is to invest in breakthrough technologies and disruptive business models in the areas of healthcare and agriculture.
Jürgen is currently a board member of BlueRock, Joyn Bio, Dewpoint, Khloris, Oerth Bio, Immunitas and eGenesis. Before joining Bayer in 2016, Jürgen Eckhardt was head of the venture capital franchise at Bellevue Asset Management in Switzerland. Previously, he was a management consultant and Associate Partner with McKinsey & Co. in Zürich and New York and a member of the Healthcare Leadership Team.
He began his career as a radiologist at the University Hospital of Basel, Switzerland. Jürgen received his M.D. from the University of Basel and his MBA from INSEAD in Fontainebleau, France.
Leaps by Bayer
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science